Effects of selective catechol-O-methyltransferase inhibitors on single-trial passive avoidance retention in male rats

Behavioural Brain Research

Volumn 86, Issue 1, 1997, Pages 49-57

  Khromova, Irina ^a   Voronina, Tatyana ^a   Kraineva, Vera A ^a   Zolotov, Nikolai ^a   Männistö, Pekka T ^b,c  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Acetylcholine; Catechol O methyltransferase inhibitors; Entacapone; Mustard; Passive avoidance; Scopolamine amnesia; Tolcapone

Indexed keywords

CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINE ACETYLTRANSFERASE; ENTACAPONE; ETHYLCHOLINE MUSTARD AZIRIDINIUM; SCOPOLAMINE; TOLCAPONE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPARKINSON AGENTS; AVOIDANCE LEARNING; AZIRIDINES; BENZOPHENONES; BRAIN MAPPING; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; CHOLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXTINCTION, PSYCHOLOGICAL; MALE; MENTAL RECALL; NEURAL PATHWAYS; NEUROMUSCULAR BLOCKING AGENTS; NITROPHENOLS; RATS; RATS, WISTAR; REACTION TIME; RETENTION (PSYCHOLOGY); SCOPOLAMINE; SUBSTANTIA INNOMINATA;

EID: 0030952242     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(96)02242-5     Document Type: Article

References (64)

1. Bäckström, R., Honkanen, E., Pippuri, A., Kairisalo, P., Pystynen, J., Heinola, K., Nissinen, E., Lindén, I.-B., Männistö, P.T., Kaakkola, S. and Pohto, P., Synthesis of some novel potent and selective catechol-O-methyltransferase inhibitors, J. Med. Chem., 32 (1989) 841-846.
2. Bartus, R.T., Dean III, R.L., Beer, B. and Lippa, A.S., The cholinergic hypothesis of geriatric memory dysfunction, Science, 217 (1982) 408-417.
3. Bartus, R.T., Flicker, C., Dean, R.L., Pontecorvo, M., Figueiredo, J.C. and Fischer, S.K., Selective memory loss following nucleus basalis lesion: long-term behavioral recovery despite persistent cholinergic deficiencies, Pharmacol. Biochem. Behav., 23 (1985) 125-135.
4. Beani, L., Bianchi, C. and Castellucci, A., Correlation of brain catecholamines with cortical acetylcholine outflow, behaviour and electrocorticogram, Eur. J. Pharmacol., 26 (1974) 63-72.
5. Borgulya, J., Bruderer, H., Bernauer, K., Zürcher, G. and Da Prada, M., Catechol-O-methyltransferase-inhibiting pyrocatechol derivatives - synthesis and structure-activity studies, Helv. Chim. Acta, 72 (1989) 952-968.
6. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72 (1976) 248-254.
7. Bushnell, P.J. and Levin, E.D., Effects of dopaminergic drugs on working and reference memory in rats, Pharmacol. Biochem. Behav., 45 (1993) 765-776.
8. Canavan, A.G.M., Passingham, R.E.P., Marsden, C.D., Quinn, N., Wyke, M. and Polkey, C.E., The performance on learning tasks of patients in the early stage of Parkinson's disease, Neuropsychologia, 27 (1989) 141-156.
9. Castellano, C., Cestari, V., Cabib, S. and Puglisi-Allegra, S., Post-training dopamine receptor agonists affect memory storage in mice, Behav. Neural Biol., 56 (1991) 283-291.
10. Cedarbaum, J.M. and Schleifer, L.S., Drugs for Parkinson's disease, spasticity, and acute muscle spasms. In A.G. Gilman, T.W. Rail, A.S. Nies and P. Taylor (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edn., Pergamon Press, New York, 1990, pp. 463-484.
11. Cestari, V., Castellano, C., Cabib, S. and Puglisiallegra, S., Strain-dependent effects of post-training dopamine receptor agonists and antagonists on memory storage in mice, Behav. Neural Biol., 58 (1992) 58-63.
12. Corrodi, H., Fuxe, K. and Lidbrink, P., Interaction between cholinergic and catecholaminergic neurons in rat brain, Brain Res., 43 (1972) 407-416.
13. Day, J. and Fibiger, H.C., Dopaminergic regulation of cortical acetylcholine release, Synapse, 12 (1992) 281-286.
14. Doyle, E., Nolan, P.M. and Regan, C.M., Learning-induced change in neural activity during acquisition and consolidation of a passive avoidance response in the rat, Neurochem. Res., 15 (1990) 551-558.
15. Fisher, A. and Hanin, I., Potential animal model for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity, Annu. Rev. Pharmacol. Toxicol., 26 (1986) 161-181.
16. Flood, I.F. and Cherkin, A., Scopolamine effects on memory retention in mice: a model for dementia? Behav. Neural Biol., 45 (1986) 169.
17. Fonnum, F., Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activities, Biochem. J., 115 (1969) 465-472.
18. Gorell, J.M. and Czarnecki, B., Pharmacological evidence for direct dopaminergic regulation of striatal acetylcholine release, Life Sci., 38 (1986) 2239-2246.
19. Gower, A.J., Lesioning of the nucleus basalis in the rat as a model of Alzheimer's disease, Trends Pharmacol. Sci., 7 (1986) 432-434.
20. Hagan, J.J. and Morris, R.G.M., The cholinergic hypothesis of memory: a review of animal experiments, Handbook Psychopharmacol., 20 (1988) 237-323.
21. Hughes, A.J., Daniel, S.E., Blankson, S. and Lees, A.J., A clinicopathologic study of 100 cases of Parkinson's disease, Arch. Neural., 50 (1993) 140-148.
22. Imperato, A., Obinu, M.C. and Gessa, G.L., Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus, Brain Res., 618 (1993) 341-345.
23. Ishihara, K., Nabeshima, T. and Kameyama, T., Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice, Pharmacol. Biochem. Behav., 30 (1988) 107-113.
24. Kaakkola, S., Gordin, A. and Männistö, P.T., General proper-ties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase (COMT), Gen. Pharmacol., 25 (1994) 813-824.
25. Kaakkola, S. and Wurtman, R.J., Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study, Brain Res., 587 (1992) 241-249.
26. Kebabian, J.W. and Neumeyer, J.L. (Eds.), The RBI Handbook of Receptor Classification, 1st edn., Research Biochemicals, Natick, MA, 1994, 122p.
27. Kelland, M.D., Freeman, A.S., Rubin, J. and Chiodo, L.A., Ascending afferent regulation of rat midbrain dopamine neurons, Brain Res. Bull., 31 (1993) 539-546.
28. Levin, E.D., Mcgurk, S.R., Rose, J.E. and Butcher, L.L., Cholinergic-dopaminergic interactions in cognitive performance, Behav. Neural Biol., 54 (1990) 271-299.
29. Levin, E.D. and Rose, J.E., Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance, Pharmacol. Biochem. Behav., 38 (1991) 243-246.
30. Liljequist, R., Haapalinna, A., Li, Z.H., Ahlander, M. and Männistö, P.T., Catechol-O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats, Behav. Brain Res., 87 (1997) 195-202.
31. Männistö, P.T. and Kaakkola, S., Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease, Pharmacol. Toxicol., 66 (1990) 317-323.
32. Mouton, P.R. and Arendash, G.W., Atrophy of cholinergic neurons within the rat nucleus basalis magnocellularis following intracortical AF64A infusion, Neurosci. Lett., 111 (1990) 52-57.
33. Männistö, P.T., Kutepova, O., Leinonen, K., Lang, A., Soosaar, A., Suomela, A. and Borisenko, S.A., Amiridin (NIK-247) and cerebrocrast in the alleviation of cholinergic lesion-induced learning deficit in male rats, Drug Develop. Res., 30 (1993) 219-228.
34. Männistö, P.T., Tuomainen, P., Kutepova, O., Borisenko, S.A., Zolotov, N. and Voronina, N., Effects of bilateral cholinotoxin infusions on the behavior and brain biochemistry of the rats, Pharmacol. Biochem. Behav., 49 (1994) 33-40.
35. Männistö, P.T., Tuomainen, P. and Tuominen, R.K., Different in vivo properties of three new inhibitors of catechol-O-methyltransferase in the rat, Br. J. Pharmacol., 105 (1992) 569-574.
36. Männistö, P.T., Ulmanen, I., Lundström, K., Taskinen, J., Tenhunen, J., Tilgmann, C. and Kaakkola, S., Characteristics of catechol-O-methyltransferase (COMT) and properties of selective COMT inhibitors, Prog. Drug Res., 39 (1992) 291-350.
37. Maj, J., Rogóz, Z., Skuza, G., Sowinska, H. and Superata, J., Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinsons disease, J. Neural Transm. [P-D Sect.], 2 (1990) 101-112.
38. Matsuoka, N., Maeda, N., Yamazaki, M., Ohkubo, Y. and Yamaguchi, I., Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks, J. Pharmacol. Exp. Ther., 263 (1992) 436-444.
39. McGurk, S.R., Levin, E.D. and Butcher, L.L., Dopaminergic drugs reverse the impairment of radial-arm maze performance caused by lesions involving the cholinergic medial pathway, Neuroscience, 50 (1992) 129-135.
40. Nakamura, S., Tani, Y., Maezono, Y., Ishihara, T. and Ohno, T., Learning deficits after unilateral AF64A lesions in the rat basal forebrain - role of cholinergic and noncholinergic systems, Pharmacol. Biochem. Behav., 42 (1992) 119-130.
41. Nissinen, E., Lindén, I.E., Schultz, E. and Pohto, P., Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone, Naunyn-Schmied. Arch. Pharmacol., 346 (1992) 262-266.
42. Packard, M.G. and White, N.M., Memory facilitation produced by dopamine agonists - role of receptor subtype and mnemonic requirements, Pharmacol. Biochem. Behav., 33 (1989) 511-518.
43. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 1st edn., Academic Press, London. 1982.
44. Pazzagli, A. and Pepeu, G., Amnestic properties of scopolamine and brain acetylcholine in the rat, Int. J. Neuropharmacol., 4 (1964) 291-299.
45. Pontecorvo, M.J. and Clissold, D.B., Are better, more selective tests of cognitive performance by animals really necessary for the development of effective treatments for Alzheimer's disease. Commentary on Dawson, Heyes and Iversen: Pharmacological mechanisms and animal models of cognition in Behav. Pharmacol. 1992:3:285-297, Behav. Pharmacol., 3 (1992) 301-305.
46. Pontecorvo, M.J. and Clissold, D.B., Are better, more selective tests of cognitive performance by animals really necessary for the development of effective treatments for Alzheimer's disease. Commentary on Dawson, Heyes and Iversen: Pharmacological mechanisms and animal models of cognition in Behav. Pharmacol. 1992:3:285-297, Behav. Pharmacol., 3 (1992) 301-305.
47. Raab, A. and Kojer, G., A10 lesion and passive avoidance latency: correlation with limbic tyrosine-hydroxylase-activity, Pharmacol. Biochem. Behav., 17 (1982) 77-83.
48. Rush, D.K., Scopolamine amnesia of passive avoidance: a deficit of information acquisition, Behav. Neural Biol., 50 (1988) 255-274.
49. Sahgal, A., Passive avidance procedures. In A. Sahgal (Ed.), Behavioural Neuroscience. A Practical Approach, Vol. I, 1st edn., IRL Press, Oxford, 1993, pp. 49-56.
50. Sara, S.J., Memory retrieval deficits: alleviation by etiracetam, a nootropic drug, Psychopharmacology, 68 (1980) 235-241.
51. Sara, S.J. and Lafevre, D., A rexamination of the role of familiarization in retrograde amnesia, J. Comp. Physiol. Psychol., 84 (1973) 361-364.
52. Siegel, S., Nonparametric statistics for the behavioral sciences, 2nd edn., McGraw-Hill Kogashaga, Tokyo, 1956, pp. 145-151.
53. Smith, R.D., Grzelak, M.E. and Coffin, V.L., Methylatropine blocks the central effects of cholinergic antagonists, Behav. Pharmacol., 5 (1994) 167-175.
54. Smith, R.D., Kistler, M.K., Cohen-Williams, M. and Coffin, V.L., Cholinergic improvement of a naturally-occurring memory deficit in the young rat, Brain Res., 707 (1996) 13-21.
55. Tallarida, R.J. and Murray, R.B., Manual of Pharmacological Calculations with Computer Programs, 2nd edn., Springer-Verlag, Berlin, 1987, 297p.
56. Tsai, C.-H., Lu, C.-S., Hua, M.-S., Lo, W.-L. and Lo, S.-K., Cognitive dysfunction in early onset parkinsonism, Acta Neurol. Scand., 89 (1994) 9-14.
57. Vanderwolf, C.H., Near-total loss of 'learning' and 'memory' as a result of combined cholinergic and serotonergic blockade in the rat, Behav. Brain Res., 23 (1987) 43-57.
58. 2 dopamine receptor participation in learning and memory in mice, Meth. Find. Exp. Clin. Pharmacol., 15 (1993) 597-607.
59. Voronina, T.A., Present-day problems in experimental psychopharmacology of nootropic drugs. Investigating of nootropic drugs. Psychopharmacology of nootropic drugs, Sov. Med. Rev. G. Neuropharmacol., 2 (1992) 51-106.
60. Voronina, T.A. and Seredenin, S.B., Analysis of the mechanism of psychotropic actions of 3-hydroxypyridine derivatives, Ann. Inst. Super. Sanita, 24 (1988) 461-466.
61. Weingartner, H., Burns, S., Diebel, R. and LeWitt, P.A., Cognitive impairments in Parkinson's disease: Distinguishing between effort-demanding and automatic cognitive processes, Psychiatry Res., 11 (1984) 223-225.
62. Whishaw, I.Q. and Dunnett, S.B., Dopamine depletion, stimulation or blockade in the rat disrupts spatial navigation and locomotion dependent upon beacon or distal cues, Behav. Brain Res., 18 (1985) 11-29.
63. White, N.M., Packard, M.G. and Seamans, J., Memory enhancement by post-training peripheral administration of low doses of dopamine agonists - possible autoreceptor effect, Behav. Neural Biol., 59 (1993) 230-241.
64. Zhang, Z.-J., Berbos, T.G., Wrenn, C.C. and Wiley, R.G., Loss of nucleus basalis magnocellularis, but not septal, cholinergic neurons correlates with passive avoidance impairment in rats treated with 192-saporin, Neurosci. Lett., 203 (1996) 214-218.